Envoy Medical, Inc. Quarterly Operating Income (Loss) in USD from Q4 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Envoy Medical, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q4 2020 to Q2 2024.
  • Envoy Medical, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$4.86M, a 8.48% decline year-over-year.
  • Envoy Medical, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$19.9M, a 36.5% decline year-over-year.
  • Envoy Medical, Inc. annual Operating Income (Loss) for 2023 was -$18.4M, a 111% decline from 2022.
  • Envoy Medical, Inc. annual Operating Income (Loss) for 2022 was -$8.71M, a 67.3% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 -$4.86M -$380K -8.48% Jun 30, 2024 10-Q 2024-08-12
Q1 2024 -$4.9M -$1.13M -29.9% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$6.74M -$2.22M -49% Dec 31, 2023 10-K 2024-04-01
Q3 2023 -$3.39M -$1.59M -88.5% Sep 30, 2023 10-Q/A 2024-01-17
Q2 2023 -$4.48M -$3.58M -397% Jun 30, 2023 10-Q 2024-08-12
Q1 2023 -$3.77M -$2.28M -153% Mar 31, 2023 10-Q 2024-05-15
Q4 2022 -$4.52M -$4.34M -2396% Dec 31, 2022 10-K 2024-04-01
Q3 2022 -$1.8M +$1.19M +39.9% Sep 30, 2022 10-Q/A 2024-01-17
Q2 2022 -$901K +$170K +15.9% Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$1.49M -$523K -54.1% Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$181K -$180K Dec 31, 2021 10-K 2023-04-03
Q3 2021 -$2.99M Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$1.07M Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$966K Mar 31, 2021 10-Q 2022-05-16
Q4 2020 -$701* Dec 31, 2020 10-K 2022-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.